{"id":"NCT01072448","sponsor":"Novartis","briefTitle":"12-week Efficacy of Indacaterol","officialTitle":"A 12-week Treatment, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Once Daily Indacaterol in Patients With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-01","primaryCompletion":"2010-07","completion":"2010-07","firstPosted":"2010-02-22","resultsPosted":"2011-08-19","lastUpdate":"2011-08-19"},"enrollment":323,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"Indacaterol 75 μg","otherNames":[]},{"type":"DRUG","name":"Placebo to indacaterol","otherNames":[]}],"arms":[{"label":"Indacaterol 75 μg","type":"EXPERIMENTAL"},{"label":"Placebo to indacaterol","type":"PLACEBO_COMPARATOR"}],"summary":"This 12-week study evaluated the efficacy and safety of indacaterol versus placebo.","primaryOutcome":{"measure":"Trough Forced Expiratory Volume in 1 Second (FEV1) 24 Hours Post-dose at the End of the Study (Week 12 + 1 Day, Day 85)","timeFrame":"24 hours post-dose at the end of the study (Week 12 + 1 day, Day 85)","effectByArm":[{"arm":"Indacaterol 75 μg","deltaMin":1.38,"sd":0.013},{"arm":"Placebo to Indacaterol","deltaMin":1.26,"sd":0.013}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":7},"locations":{"siteCount":62,"countries":["United States"]},"refs":{"pmids":["23020650","22177371"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":163},"commonTop":["Chronic obstructive pulmonary disease","Headache","Urinary tract infection"]}}